The Negative Prognostic Significance of Low Lymphocyte-To-Monocyte Ratio (LMR) in Both Advancer Cancer and in the Acute Phase of the Autoimmune Diseases: How to Explain the Same Significance in Pathologies Characterized by an Opposite Immune Status?

Paolo Lissoni, Giusy Messina, Alessio Tosatto, Gianmaria Borsotti, Stefano Frigerio and Simonetta Tassoni
Additional contact information
Stefano Frigerio: Institute of Biological Medicine, Milan, Italy
Simonetta Tassoni: Effata Institute, Lucca, Italy

Biomedical Journal of Scientific & Technical Research, 2020, vol. 27, issue 3, 20709-20712

Abstract: The recent clinical studies performed to in vivo investigate the immune functions have shown that lymphocyte-to-monocyte ratio (LMR) may be considered...

Keywords: Autoimmunity; Cancer; Cytokines; Lymphocyte-to-Monocyte Ratio; Interleukin-2; Transforming growth factor-beta (search for similar items in EconPapers)
Date: 2020
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://biomedres.us/pdfs/BJSTR.MS.ID.004490.pdf (application/pdf)
https://biomedres.us/fulltexts/BJSTR.MS.ID.004490.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:abf:journl:v:27:y:2020:i:3:p:20709-20712

DOI: 10.26717/BJSTR.2020.27.004490

Access Statistics for this article

Biomedical Journal of Scientific & Technical Research is currently edited by Robert Thomas

More articles in Biomedical Journal of Scientific & Technical Research from Biomedical Research Network+, LLC
Bibliographic data for series maintained by Angela Roy ().